- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 58.95M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 58.16M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 58.46M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $15.81M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $37.46M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $38.99M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.35B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $1.35B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $130.11M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $170.39M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $70.94M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $101.84M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.99B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.04B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.47B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.49B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.47B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.54B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.30 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.30 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $10.25M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $10.39M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$239K |
| Net Income | Q1 2026 · Mar 31, 2025 | $18.98M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $16.74M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $17.13M |
| Revenue | Q1 2026 · Mar 31, 2026 | $972K |
| Revenue | Q1 2026 · Mar 31, 2025 | $970K |